Literature DB >> 15740667

Anti-tumor effect of pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism.

Wei Yang1, Xiu-yi Li.   

Abstract

BACKGROUND: Gene-radiotherapy, the combination of gene therapy and radiation therapy, is a new paradigm for cancer treatment. To enhance anti-tumor effect of gene-radiotherapy, in this study we construct a radiation-inducible dual-gene co-expression vector pEgr-interferon (IFN)-gamma-endostatin and studied the anti-tumor effect of pEgr-IFN-gamma-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism.
METHODS: Gene recombinant technique was used to construct dual-gene co-expression plasmid pEgr-IFN-gamma-endostatin, and single-gene expression plasmid pEgr-IFN-gamma and pEgr-endostatin. The plasmids packed by liposome were injected locally into the tumors of the mice, and the tumors were irradiated with 5 Gy X-ray 36 hours later. The tumor growth rate at different time and mean survival period of the mice were observed. Cytotoxic activity of splenic cytotoxic T-lymphocyte (CTL), natural killer (NK) cell and tumor necrosis factor (TNF)-alpha secretion activity of peritoneal macrophages of the mice in various groups were evaluated 15 days after irradiation. The intratumor micro-vessel density was evaluated by immunohistochemical staining 10 days after irradiation.
RESULTS: The tumor growth rate of the mice in dual-gene-radiotherapy group was significantly lower than those in control group, 5 Gy group and single-gene-radiotherapy group at different time after gene-radiotherapy, and the mean survival period of which was longer. Cytotoxic activity of splenic CTL, NK and TNF-alpha secretion activity of peritoneal macrophages of the mice in dual-gene-radiotherapy group were significantly higher than those in control group, 5 Gy X-ray irradiation group and pEgr-endostatin gene-radiotherapy group 15 days after irradiation. The intratumor micro-vessel density of the mice in dual-gene-radiotherapy group was significantly lower than those in control group, 5 Gy X-ray irradiation group and pEgr-IFN-gammagene-radiotherapy group.
CONCLUSION: The anti-tumor effect of dual-gene-radiotherapy was significantly better than that of single-gene-radiotherapy by combining the enhancement of anti-tumor immunologic function induced by IFN-gamma with the anti-angiogenesis function of endostatin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15740667

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  6 in total

1.  Enhanced effects of TRAIL-endostatin-based double-gene-radiotherapy on suppressing growth, promoting apoptosis and inducing cell cycle arrest in vascular endothelial cells.

Authors:  Yanbo Li; Caixia Guo; Zhicheng Wang; Pingsheng Gong; Zhiwei Sun; Shouliang Gong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

2.  Anti-tumor effect of 125I-UdR in combination with Egr-1 promoter-based IFNγ gene therapy in vivo.

Authors:  Wei Yang; Jing-Guo Zhao; Xiu-Yi Li; Shou-Liang Gong; Jian-Ping Cao
Journal:  Radiat Environ Biophys       Date:  2010-07-03       Impact factor: 1.925

3.  The effect of endostatin mediated by human mesenchymal stem cells on ovarian cancer cells in vitro.

Authors:  Jing Jiang; Wei Chen; Rujin Zhuang; Tiefang Song; Peiling Li
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-17       Impact factor: 4.553

4.  Hypoxia- and radiation-induced overexpression of Smac by an adenoviral vector and its effects on cell cycle and apoptosis in MDA-MB-231 human breast cancer cells.

Authors:  Wei-Wu Liu; Yang Liu; Shuo Liang; Jia-Hui Wu; Zhi-Cheng Wang; Shou-Liang Gong
Journal:  Exp Ther Med       Date:  2013-10-16       Impact factor: 2.447

5.  Lentiviral vector with a radiation-inducible promoter, carrying the ING4 gene, mediates radiosensitization controlled by radiotherapy in cervical cancer cells.

Authors:  Tao Ma; Rui Guo; Xi Wang; Wen-Tong Shen; Min Zhu; Ye-Ning Jin; Hao-Ping Xu
Journal:  Oncol Lett       Date:  2020-11-25       Impact factor: 2.967

6.  Dysregulation of CXCL9 and reduced tumor growth in Egr-1 deficient mice.

Authors:  Giuseppe Caso; Catherine Barry; Gerald Patejunas
Journal:  J Hematol Oncol       Date:  2009-02-07       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.